Sakar Healthcare Secures 14 Oncology Approvals in EU, UK, and Canada
Sakar Healthcare Limited has secured 14 new regulatory approvals for its oncology products across the European Union, the UK, and Canada, including six site variations approved by the European Medicines Agency under a technology transfer pact with Accord Healthcare. These approvals expand the company's oncology portfolio covering multiple cancer types. The company reported a 38% year-on-year revenue increase to Rs 72.97 crore and a net profit rise to Rs 10.28 crore. Managing Director Sanjay Shah highlighted the progress as validation of their oncology investments and growth strategy.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 41/100.
Outlets measured: english, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 1 Sept, 01:30 pm. Other outlets followed.
- 1